Effects of esketamine on perioperative renal injury in paediatric patients undergoing living donor liver transplantation
World Journal of Gastrointestinal Surgery · 27.06.2026 · 18 (6)
DOI: 10.4240/wjgs.119494 ↗Kurz gefasst
Fachartikel in der Zeitschrift World Journal of Gastrointestinal Surgery, online erschienen am 27.06.2026. Verfasst von Hong-Xia Li und 7 weiteren Autor:innen. Die Arbeit nennt 25 Literaturangaben.
Abstract (Originalsprache)
BACKGROUND Living-donor liver transplantation (LDLT) is the definitive treatment for end-stage paediatric liver disease; however, acute kidney injury (AKI) occurs in 40%-70% of cases and significantly affects mortality and clinical outcomes. Esketamine has demonstrated anti-inflammatory and organ-protective properties in preclinical studies, but its renoprotective effects in paediatric LDLT have not been established. AIM To determine whether intraoperative administration of esketamine reduces perioperative AKI and attenuates the inflammatory response in paediatric LDLT. METHODS This randomised, double-blind, placebo-controlled trial was conducted at a tertiary transplant centre in China. Sixty paediatric patients (aged 5-15 months) undergoing LDLT were randomly assigned (1:1) to receive intraoperative esketamine (group E; 0.5 mg/kg at induction followed by 0.5 mg/kg/hour infusion) or placebo (group C). Blood samples were collected at five time points to measure serum creatinine (Scr), tumour necrosis factor, interleukin (IL)-18, IL-10, and neutrophil gelatinase-associated lipocalin (NGAL). Between-group comparisons used independent t -tests or Mann-Whitney U tests. RESULTS Group E demonstrated lower Scr at 3 hours post-reperfusion (40.56 ± 15.4 μmol/L vs 60.37 ± 15.4 μmol/L, P < 0.05), 24 hours postoperatively (36.35 ± 8.96 μmol/L vs 58.93 ± 12.57 μmol/L, P < 0.05), and 72 hours postoperatively (34.64 ± 5.66 μmol/L vs 53.51 ± 8.69 μmol/L, P < 0.05). Serum tumour necrosis factor, IL-18, and NGAL levels were also reduced in group E at time points T2-T5 (P < 0.05). Mechanical ventilation duration was shorter in group E (168.55 ± 69.64 minutes vs 264.55 ± 73.64 minutes, P < 0.001). CONCLUSION Intraoperative administration of esketamine attenuates the increase in Scr levels following ischemia-reperfusion injury and attenuates the systemic inflammatory response in paediatric LDLT recipients.
Zitieren
APA
Li, H., Cao, G., Weng, Y., Dong, A., Gao, W., Zhu, M., Che, L., & Yu, W. (2026). Effects of esketamine on perioperative renal injury in paediatric patients undergoing living donor liver transplantation. World Journal of Gastrointestinal Surgery, 18(6). https://doi.org/10.4240/wjgs.119494
Vancouver
Li H, Cao G, Weng Y, Dong A, Gao W, Zhu M, et al. Effects of esketamine on perioperative renal injury in paediatric patients undergoing living donor liver transplantation. World Journal of Gastrointestinal Surgery. 2026;18(6). doi:10.4240/wjgs.119494
BibTeX
@article{Li2026,
author = {Li, Hong-Xia and Cao, Gui-Zhu and Weng, Yi-Qi and Dong, Ai-Li and Gao, Wei and Zhu, Min and Che, Lu and Yu, Wen-Li},
title = {Effects of esketamine on perioperative renal injury in paediatric patients undergoing living donor liver transplantation},
journal = {World Journal of Gastrointestinal Surgery},
year = {2026},
volume = {18},
number = {6},
doi = {10.4240/wjgs.119494}
}
EUVIMED